D
Datadrivenbioscience.com
Data Driven Bioscience enables clinical cancer genomics by providing integrated kits and software for cancer diagnosis
About Datadrivenbioscience.com
Data Driven Bioscience Inc. is a biotechnology company that provides tools for clinical laboratories to implement genomics in the diagnosis and treatment of cancer. The company offers integrated kits and software for cancer diagnosis, which includes a single workflow for DNAseq and RNAseq extraction, library preparation, and sequencing. This allows for the identification of patients who are suitable for personalized therapies.
The company primarily serves clinical laboratories, providing them with the necessary tools to advance their genomic testing capabilities. Data Driven Bioscience operates in the cancer diagnostics market, a sector that is increasingly adopting genomic technologies for more precise and effective treatments. The business model is centered on the sale of these integrated kits and software solutions to clinical labs.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- Durham, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
- SGSAR GROUP
Y Combinator
Series A3 investors entered at this stage
Rembrandt Venture Partners
Bain Capital Ventures
IT-Farm
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Datadrivenbioscience.com on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Datadrivenbioscience.com on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.